Works by Wang, Jianhong

Results: 194
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703).

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. e1693, doi. 10.1002/onco.13857
    By:
    • Chi, Yihebali;
    • Shu, Yongqian;
    • Ba, Yi;
    • Bai, Yuxian;
    • Qin, Baoli;
    • Wang, Xiuwen;
    • Xiong, Jianping;
    • Xu, Nong;
    • Zhang, Helong;
    • Zhou, Jianfeng;
    • Xu, Jianming;
    • Cheng, Ying;
    • Feng, Jifeng;
    • Hu, Chunhong;
    • Chen, Yigui;
    • Chen, Zhendong;
    • Wang, Jufeng;
    • Dang, Chengxue;
    • Wang, Jianhong;
    • Wan, Yiye
    Publication type:
    Article
    11
    12

    Adaptive Internal Model Control Based on Parameter Adaptation.

    Published in:
    Electronics (2079-9292), 2022, v. 11, n. 23, p. 3842, doi. 10.3390/electronics11233842
    By:
    • Chen, Peng;
    • Zhang, Yunfeng;
    • Wang, Jianhong;
    • Azar, Ahmad Taher;
    • Hameed, Ibrahim A.;
    • Ibraheem, Ibraheem Kasim;
    • Kamal, Nashwa Ahmad;
    • Abdulmajeed, Farah Ayad
    Publication type:
    Article
    13
    14
    15
    16
    17

    Author Correction: Ultrafast light-activated polymeric nanomotors.

    Published in:
    2024
    By:
    • Wang, Jianhong;
    • Wu, Hanglong;
    • Zhu, Xiaowei;
    • Zwolsman, Robby;
    • Hofstraat, Stijn R. J.;
    • Li, Yudong;
    • Luo, Yingtong;
    • Joosten, Rick R. M.;
    • Friedrich, Heiner;
    • Cao, Shoupeng;
    • Abdelmohsen, Loai K. E. A.;
    • Shao, Jingxin;
    • van Hest, Jan C. M.
    Publication type:
    Correction Notice
    18

    Ultrafast light-activated polymeric nanomotors.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49217-w
    By:
    • Wang, Jianhong;
    • Wu, Hanglong;
    • Zhu, Xiaowei;
    • Zwolsman, Robby;
    • Hofstraat, Stijn R. J.;
    • Li, Yudong;
    • Luo, Yingtong;
    • Joosten, Rick R. M.;
    • Friedrich, Heiner;
    • Cao, Shoupeng;
    • Abdelmohsen, Loai K. E. A.;
    • Shao, Jingxin;
    • van Hest, Jan C. M.
    Publication type:
    Article
    19
    20
    21
    22
    23

    Phase 2 Study Design and New Data from the Phase 1 SAD/MAD Trial of LHP588, A Second‐Generation Gingipain Inhibitor for the Treatment of P. Gingivalis ‐ Positive Alzheimer Dementia.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082502
    By:
    • Detke, Michael;
    • Sabbagh, Marwan;
    • Holsinger, Leslie J;
    • Bolger, Joanna;
    • Wang, Jianhong;
    • Ryder, Mark;
    • Hendrix, Suzanne B.;
    • Dickson, Samuel P.;
    • Mallinckrodt, Craig;
    • Lynch, Casey C;
    • Dominy, Stephen S
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Human pharmacokinetics prediction with an in vitro–in vivo correction factor approach and in vitro drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy<sup>®</sup> for the treatment of HIV-1 infection

    Published in:
    Xenobiotica, 2022, v. 52, n. 12, p. 1020, doi. 10.1080/00498254.2023.2169207
    By:
    • Subramanian, Raju;
    • Wang, Jianhong;
    • Murray, Bernard;
    • Custodio, Joseph;
    • Hao, Jia;
    • Lazerwith, Scott;
    • MacLennan Staiger, Kelly;
    • Mwangi, Judy;
    • Sun, Hailing;
    • Tang, Jennifer;
    • Wang, Kelly;
    • Rhodes, Gerry;
    • Wijaya, Samantha;
    • Zhang, Heather;
    • Smith, Bill J.
    Publication type:
    Article
    46
    47
    48
    49
    50